Unions and health insurers cannot pursue a nationwide class action consumer fraud case for billions of dollars spent on the painkiller Vioxx, the New Jersey Supreme Court says. The justices on Thursday reversed lower court rulings that certified the suit by third-party payors against Merck & Co. The plaintiff, a union fund, had sued under New Jersey's Consumer Fraud Act to recover extra amounts paid for Vioxx prescriptions due to an allegedly fraudulent marketing scheme that drove up the price.
September 07, 2007 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Unions and health insurers cannot pursue a nationwide class action consumer fraud case for billions of dollars spent on the painkiller Vioxx, the New Jersey Supreme Court says.
The justices on Thursday reversed lower court rulings that certified the suit by third-party payers against Merck & Co. Inc., which sold the painkiller from 1999 until withdrawing it from the market in 2004.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
Health Law Associate CT Shipman is seeking an associate to join our national longstanding health law practice. Candidates must have t...
Shipman & Goodwin LLP is seeking two associates to expand our national commercial real estate lending practice. Candidates should have ...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
